Search Results 161-170 of 17325 for metformin interactions

1. Ezetimibe and simvastatin (oral route) - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

2. Investigational Extended Wear Insulin Infusion Set During Home Use for Type 1 Diabetes - Mayo Clinic

   Concurrent use of any non-insulin glucose-lowering agent, other than metformin (for example, GLP-1 agonists, Symlin, DPP-4 inhibitors, SGLT-2 inhibitors, ...

3. Ginkgo - Mayo Clinic

   Interactions · Alprazolam (Xanax). This medicine relieves symptoms of anxiety. · Anticoagulants and antiplatelet drugs, herbs and supplements. · Anticonvulsants ...

4. Tranylcypromine (oral route) - Side effects & dosage - Mayo Clinic

   Drug Interactions. Although certain medicines ... interaction might occur. In these cases, your ... Metformin; Nateglinide; Repaglinide; Tolazamide ...

5. Glipizide (oral route) - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

6. Eplerenone (oral route) - Side effects & dosage - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

7. Lisinopril and hydrochlorothiazide (oral route) - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

8. Tramadol and acetaminophen (oral route) - Side effects & dosage - Mayo Clinic

   An alternative to this medication should be prescribed or you should stop breastfeeding while using this medicine. Drug Interactions. Although certain medicines ...

9. A Study of the Safety, Tolerability, and Drug/Body Interactions of C2N-8E12 in People with Progressive Supranuclear Palsy - Mayo Clinic

   The purpose of this study is to evaluate the safety, tolerability and drug/body interactions of C2N-8E12 in patients with progressive supranuclear palsy.

10. The International Diabetes Closed Loop Trial DCLP4 - Mayo Clinic

    Use of Afrezza or any non-insulin glucose-lowering agent other than metformin (including GLP-1 agonists, DPP-4 inhibitors, SGLT-2 inhibitors, sulfonylureas) ...